Loring Wolcott & Coolidge Fiduciary Advisors’s iShares MBS ETF MBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-214
Closed -$18.8K 582
2023
Q3
$18.8K Buy
+214
New +$19.6K ﹤0.01% 486
2023
Q2
Sell
-598
Closed -$56.6K 652
2023
Q1
$56.6K Buy
+598
New +$56.5K ﹤0.01% 393
2022
Q1
Sell
-75
Closed -$8K 685
2021
Q4
$8K Hold
75
﹤0.01% 630
2021
Q3
$8K Sell
75
-698
-90% -$75.7K ﹤0.01% 623
2021
Q2
$84K Buy
+773
New +$83.8K ﹤0.01% 420
2016
Q1
Sell
-125
Closed -$13K 634
2015
Q4
$13K Hold
125
﹤0.01% 544
2015
Q3
$14K Hold
125
﹤0.01% 517
2015
Q2
$14K Hold
125
﹤0.01% 517
2015
Q1
$14K Hold
125
﹤0.01% 539
2014
Q4
$14K Hold
125
﹤0.01% 531
2014
Q3
$14K Hold
125
﹤0.01% 505
2014
Q2
$14K Hold
125
﹤0.01% 533
2014
Q1
$13K Hold
125
﹤0.01% 524
2013
Q4
$13K Hold
125
﹤0.01% 505
2013
Q3
$13K Hold
125
﹤0.01% 472
2013
Q2
$13K Buy
+125
New +$13.4K ﹤0.01% 514

Other funds holding MBB

Loring Wolcott & Coolidge Fiduciary Advisors's MBB Position: Q4 2023 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of iShares MBS ETF (MBB) in Q4 2023, closing a stake of 214 shares — an estimated $18.8K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in MBB in Q2 2013 and held it in 16 quarters. The position peaked at $84K in Q2 2021. 858 funds tracked by Wall St. Rank hold MBB as of Q4 2023.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining iShares MBS ETF position as of Q4 2023 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 214 iShares MBS ETF shares in Q4 2023, an estimated $18.8K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in iShares MBS ETF in Q2 2013 and held it in 16 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's iShares MBS ETF position peaked at $84K in Q2 2021.
  • 858 funds tracked by Wall St. Rank held iShares MBS ETF as of Q4 2023.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.